Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase β (RPTPβ) to tenascin C

Abstract

The extracellular domain of receptor protein tyrosine phosphatase β (RPTPβ) is composed of several domains which mediate its interactions with distinct ligands present on the surface of either neurons or glial cells. Here, we demonstrate that the fibronectin type III domain (FNIII) of RPTPβ binds to glial tumor-derived cell lines and primary astrocytes. We used affinity purification to isolate several proteins that specifically bind to the FNIII domain of RPTPβ. One of these, a 240 kDa protein that was purified from U118MG glioblastoma cell, was identified as tenascin C based on the amino acid sequence of several tryptic peptides. The interaction of RPTPβ with tenascin C was found to mediate cell adhesion. Adhesion and spreading of SF763T astrocytoma cells expressing RPTPβ on tenascin C was specifically abolished by the addition of a soluble fragment containing the FNIII domain of the receptor. RPTPβ-dependent cell adhesion was mediated by binding to the alternatively spliced FNIII repeats A1,2,4 (TnfnA1,2,4) of tenascin C. Furthermore, COS cells expressing RPTPβ adhere to TnfnA1,2,4, while the parental cells did not. These results demonstrate that the FNIII domain of RPTPβ binds to tenascin C and suggest that RPTPβ present on glial tumor cells is a primary adhesion receptor system to the extracellular matrix.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Angers-Loustau A, Cote JF and Tremblay ML. . 1999 Biochem. Cell. Biol. 77: 493–505.

  • Barnea G, Grumet M, Milev P, Silvennoinen O, Levy JB, Sap J and Schlessinger J. . 1994 J. Biol. Chem. 269: 14349–14352.

  • Brady-Kalnay SM, Flint AJ and Tonks NK. . 1993 J. Cell. Biol. 122: 961–972.

  • Brady-Kalnay SM, Rimm DL and Tonks NK. . 1995 J. Cell. Biol. 130: 977–986.

  • Brady-Kalnay SM and Tonks NK. . 1995 Curr. Opin. Cell. Biol. 7: 650–657.

  • Canoll PD, Barnea G, Levy JB, Sap J, Ehrlich M, Silvennoinen O, Schlessinger J and Musacchio JM. . 1993 Brain Res. Dev. Brain Res. 75: 293–298.

  • Canoll PD, Petanceska S, Schlessinger J and Musacchio JM. . 1996 J. Neurosci. Res. 44: 199–215.

  • Chung CY, Murphy-Ullrich JE and Erickson HP. . 1996 Mol. Biol. Cell. 7: 883–892.

  • Faissner A. . 1997 Cell Tissue Res. 290: 385–393.

  • Fashena SJ and Zinn K. . 1997 Mol. Cell. Biol. 17: 6859–6867.

  • Garwood J, Schnadelbach O, Clement A, Schutte K, Bach A and Faissner A. . 1999 J. Neurosci. 19: 3888–3899.

  • Giese A, Loo MA, Norman SA, Treasurywala S and Berens ME. . 1996 J. Cell. Sci. 109: 2161–2168.

  • Goldmann T, Otto F and Vollmer E. . 2000 Folia Histochem. Cytobiol. 38: 19–20.

  • Grumet M, Milev P, Sakurai T, Karthikeyan L, Bourdon M, Margolis RK and Margolis RU. . 1994 J. Biol. Chem. 269: 12142–12146.

  • Jones FS and Jones PL. . 2000 Am. J. Respir. Crit. Care Med. 161: 2086–2091.

  • Koch T, Brugger T, Bach A, Gennarini G and Trotter J. . 1997 Glia 19: 199–212.

  • Krueger NX and Saito H. . 1992 Proc. Natl. Acad. Sci. USA 89: 7417–7421.

  • Levy JB, Canoll PD, Silvennoinen O, Barnea G, Morse B, Honegger AM, Huang JT, Cannizzaro LA, Park SH, Druck T and Schlessinger J. . 1993 J. Biol. Chem. 268: 10573–10581.

  • Maeda N, Hamanaka H, Shintani T, Nishiwaki T and Noda M. . 1994 FEBS Lett. 354: 67–70.

  • Maeda N, Nishiwaki T, Shintani T, Hamanaka H and Noda M. . 1996 J. Biol. Chem. 271: 21446–21452.

  • Margolis RU and Margolis RK. . 1997 Cell Tissue Res. 290: 343–348.

  • Milev P, Friedlander DR, Sakurai T, Karthikeyan L, Flad M, Margolis RK, Grumet M and Margolis RU. . 1994 J. Cell. Biol. 127: 1703–1715.

  • Milev P, Meyer-Puttlitz B, Margolis RK and Margolis RU. . 1995 J. Biol. Chem. 270: 24650–24653.

  • Milev P, Maurel P, Haring M, Margolis RK and Margolis RU. . 1996 J. Biol. Chem. 271: 15716–15723.

  • Milev P, Fische D, Haring M, Schulthess T & Margolis RK. . 1997 J. Biol. Chem. 272: 15501–15509.

  • Milev P, Chiba A, Haring M, Rauvala H, Schachner M, Ranscht B, Margolis RK and Margolis RU. . 1998a J. Biol. Chem. 273: 6998–7005.

  • Milev P, Monnerie H, Popp S, Margolis RK and Margolis RU. . 1998b J. Biol. Chem. 273: 21439–21442.

  • Neel BG and Tonks NK. . 1997 Curr. Opin. Cell. Biol. 9: 193–204.

  • O'Grady P, Thai TC and Saito H. . 1998 J. Cell. Biol. 141: 1675–1684.

  • Oohira A, Matsui F, Tokita Y, Yamauchi S and Aono S. . 2000 Arch. Biochem. Biophys. 374: 24–34.

  • Peles E, Nati M, Campbel PL, Sakurai T, Martinez R, Lev S, Clary DO, Schilling J, Barnea G, Plowman GD and Schlessinger J. . 1995 Cell 82: 251–260.

  • Peles E, Nativ M, Lustig M, Grumet M, Schilling J, Martinez R, Plowman GD and Schlessinger J. . 1997 EMBO J. 16: 978–988.

  • Peles E, Schlessinger J and Grumet M. . 1998 Trends Biochem. Sci. 23: 121–124.

  • Phillips GR, Krushel LA and Crossin KL. . 1998 Mol. Biol. Cell. 9: 1425–1435.

  • Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer J, Trimmer J, Shrager P and Peles E. . 1999 Neuron 24: 1037–1047.

  • Prieto AL, Edelman GM and Crossin KL. . 1993 Proc. Natl. Acad. Sci. USA 90: 10154–10158.

  • Revest JM, Faivre-Sarrailh C, Maeda N, Noda M, Schachner M and Rougon G. . 1999 Eur. J. Neurosci. 11: 1134–1147.

  • Sakurai T, Friedlander DR and Grumet M. . 1996 J. Neurosci. Res. 43: 694–706.

  • Sakurai T, Lustig M, Nativ M, Hemperly JJ, Schlessinger J, Peles E and Grumet M. . 1997 J. Cell. Biol. 136: 907–918.

  • Sap J, Jiang YP, Friedlander D, Grumet M and Schlessinger J. . 1994 Mol. Cell. Biol. 14: 1–9.

  • Schaapveld R, Wieringa B and Hendriks W. . 1997 Mol. Biol. Rep. 24: 247–262.

  • Schnapp LM, Hatch N, Ramos DM, Klimanskaya IV, Sheppard D and Pytela R. . 1995 J. Biol. Chem. 270: 23196–23202.

  • Scholze A, Gotz B and Faissner A. . 1996 Int. J. Dev. Neurosci. 14: 315–329.

  • Serra-Pages C, Kedersha NL, Fazikas L, Medley Q, Debant A and Streuli M. . 1995 EMBO J. 14: 2827–2838.

  • Serra-Pages C, Medley QG, Tang M, Hart A and Streuli M. . 1998 J. Biol. Chem. 273: 15611–15620.

  • Shenoi H, Seavitt J, Zheleznyak A, Thomas ML and Brown EJ. . 1999 J. Immunol. 162: 7120–7127.

  • Snyder SE, Li J, Schauwecker PE, McNeill TH and Salton SR. . 1996 Brain Res. Mol. Brain Res. 40: 79–96.

  • Stoker A and Dutta R. . 1998 Bioessays 20: 463–472.

  • Walzel H, Schulz U, Neels P and Brock J. . 1999 Immunol. Lett. 67: 193–202.

  • Wang J and Bixby JL. . 1999 Mol. Cell. Neurosci. 14: 370–384.

  • Wenk MB, Midwood KS and Schwarzbauer JE. . 2000 J. Cell. Biol. 150: 913–919.

  • Xiao ZC, Bartsch U, Margolis RK, Rougon G, Montag D and Schachner M. . 1997 J. Biol. Chem. 272: 32092–32101.

  • Yokosaki Y, Matsuura N, Higashiyama S, Murakami I, Obara M, Yamakido M, Shigeto N, Chen J and Sheppard D. . 1998 J. Cell. Sci. 111: 1095–1104.

  • Zagzag D, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostianovsky M, Cohen H, Grumet M and Greco MA. . 1995 Cancer Res. 55: 907–914.

  • Zeng L, D'Alessandri L, Kalousek MB, Vaughan L and Pallen CJ. . 1999 J. Cell. Biol. 147: 707–714.

  • Zisch AH, D'Alessandri L, Ranscht B, Falchetto R, Winterhalter KH and Vaughan L. . 1992 J. Cell. Biol. 119: 203–213.

  • Zondag GC and Moolenaar WH. . 1997 Biochimie 79: 477–483.

Download references

Acknowledgements

This work was supported by the Dorot foundation from the Israel Academy of Sciences and Humanities, the Yad Abraham Research Center for Cancer Diagnostics and Therapy, and a Research Career Development Award from the Israel Cancer Research Fund. E Peles is an Incumbent of the Madeleine Haas Russell Career Development Chair.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adamsky, K., Schilling, J., Garwood, J. et al. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase β (RPTPβ) to tenascin C. Oncogene 20, 609–618 (2001). https://doi.org/10.1038/sj.onc.1204119

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204119

Keywords

This article is cited by

Search

Quick links